
₹1,21,200(1,200 Shares)
Minimum Investment
IPO Dates
May 14, 2025 – May 16, 2025
Price Band
₹96–101 per equity share
Lot Size
1200
Listing
May 21, 2025
Listing At
NSE SME
Overall Subscription
Total Bids Received
7.67x
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical firm that produces and markets tablets, capsules, and other health care products.The company provides contract manufacturing...
EPS (Pre-IPO)
4.74
EPS (Post-IPO)
6.28
P/E (Pre-IPO)
21.29
P/E (Post-IPO)
16.08
RoNW
72.47%
PAT Margin
11.51%
P/B Value
7.55
* All figures are in ₹ Crores unless otherwise stated.
29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat,India, 382213
Kfin Technologies Limited
The Accretion Pharmaceuticals Limited IPO price band is set at ₹96.00 to ₹101.00 per equity share.
The lot size for Accretion Pharmaceuticals Limited IPO is 1200 shares per lot. The minimum investment amount is approximately ₹1,21,200.
The Accretion Pharmaceuticals Limited IPO opens on May 14, 2025 and closes on May 16, 2025.
Accretion Pharmaceuticals Limited IPO is expected to be listed on May 21, 2025 on NSE SME.
The current GMP for Accretion Pharmaceuticals Limited IPO is ₹0, suggesting an expected listing price of around ₹96.00. Note: GMP is an unofficial market indicator.
The registrar for Accretion Pharmaceuticals Limited IPO is Kfin Technologies Limited. You can contact them at apl.ipo@kfintech.com.